Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries
PR Newswire —
Cerapro® is a patented, skin pH-lowering cream approved for the treatment of atopic dermatitis under the European Medical Device Regulation (CE Mark) Product launch targeted for 2026 in six European markets, including Switzerland, Austria, the Netherlands and Belgium. SINGAPORE, Jan. 5,...